Calcium entry blockers and the forearm arterial bed

  • Brian F. Robinson
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 63)


The smooth muscle cells in the walls of blood vessels are endowed with several mechanisms by which the concentration of calcium in the cytosol can be raised and contraction initiated [1, 2]. One important system is that of the voltage-dependent calcium channels in the plasma membrane. Voltage-dependent channels, as their name implies, open to permit the influx of calcium when the membrane is depolarised either spontaneously or in response to a stimulus; some channels with similar characteristics are, however, thought to be linked to α2-adrenoceptors and may thus be directly activated by noradrenaline. The influx of calcium through channels of the voltage-dependent type is inhibited by calcium entry blockers such as verapamil, diltiazem and compounds of the dihydropyridine group including nifedipine and nitrendipine.


Sodium Nitroprusside Calcium Entry Resistance Vessel Forearm Blood Flow Primary Hypertension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Carafoli E (1984): How calcium crosses plasma membranes including the sarcolemma. In: Opie LH (ed) Calcium antagonists and cardiovascular disease. New York, Raven Press, pp. 29–41.Google Scholar
  2. 2.
    Triggle DJ (1985): Calcium ions and respiratory smooth muscle function. Br J Clin Pharmacol 20: 213s-219s.PubMedGoogle Scholar
  3. 3.
    Robinson BF, Collier JG, Dobbs RJ (1979): Comparative dilator effect of verapamil and sodium nitroprusside in forearm arterial bed and dorsal hand veins in man: functional differences between vascular smooth muscle in arterioles and veins. Cardiovasc Res 13: 16–21.PubMedCrossRefGoogle Scholar
  4. 4.
    Robinson BF, Dobbs RJ, Kelsey CR (1980): Effects of nifedipine on resistance vessels, arteries and veins in man. Br J Clin Pharmacol 10: 433–438.PubMedGoogle Scholar
  5. 5.
    Hulthén UL, Bolli P, Amann FW, Kiowski W, Bühler FR (1982): Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil. Hypertension, 4 suppl II: 26–31.PubMedGoogle Scholar
  6. 6.
    Robinson BF, Dobbs RJ, Bayley S (1982): Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci 63: 33–42.PubMedGoogle Scholar
  7. 7.
    Bühler FR, Bolli P, Hulthén UL (1984): Calcium influx-dependent vasoconstrictor mechanisms in essential hypertension. In: Opie LH (ed) Calcium antagonists and cardiovascular disease. New York, Raven Press, pp. 313–322.Google Scholar
  8. 8.
    Folkow B (1978): Cardiovascular structural adaptation: its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med 55 (suppl 4): 3s-22s.Google Scholar
  9. 9.
    Keatinge WR (1979): Blood-vessels. Br Med Bull 35: 249–254.PubMedGoogle Scholar
  10. 10.
    Brading AF, Lategan TW (1985): Na-Ca exchange in vascular smooth muscle. J Hypertension 3: 109–116.CrossRefGoogle Scholar
  11. 11.
    Kwan CY, Belbeck L, Daniel EE (1980): Abnormal biochemistry of vascular smooth muscle plasma membrane isolated from hypertensive rats. Mol Pharmacol 17: 137–140.PubMedGoogle Scholar
  12. 12.
    Bruschi G, Bruschi ME, Orlandini G, Cavatorta A, Borghetti A, Ferrandi M, Bianchi G (1985): Why is Cai 2+ increased in blood cells in primary hypertension?: J. Hypertension 3 (suppl 3): s45- s47.Google Scholar
  13. 13.
    Graham JM, Robinson BF, Wilson RBJ (1985): (Ca2+ + Mg2+)-ATPase activity of a platelet membrane fraction from normal subjects and patients with hypertension (Abstract). J Hypertension 3: 664.CrossRefGoogle Scholar
  14. 14.
    Resink TJ, Tkachuk VA, Erne P, Bühler FR (1986): Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase: altered activity in essential hypertension. Hypertension 8: 159–166.PubMedGoogle Scholar
  15. 15.
    Robinson BF (1984): Altered calcium handling as a cause of primary hypertension. J Hypertension 2: 453–460.CrossRefGoogle Scholar
  16. 16.
    Hilton PJ (1986): Cellular sodium transport in essential hypertension. N Engl J Med 314: 222–229.PubMedCrossRefGoogle Scholar
  17. 17.
    Phillips RJW, Robinson BF (1984): The dilator response to K+ is reduced in the forearm resistance vessels of men with primary hypertension. Clin Sci 66: 237–239.PubMedGoogle Scholar
  18. 18.
    Robinson BF, Phillips RJW, Wilson PN, Chiodini PL (1983): Effect of local infusion of ouabain on human forearm vascular resistance and on response to potassium, verapamil and sodium nitroprusside. J Hypertension 1: 165–169.CrossRefGoogle Scholar
  19. 19.
    Robinson BF, Phillips RJW (1984): Effect of small increments in plasma calcium concentration on the responsiveness of forearm resistance vessels to verapamil in normal subjects. Clin Sci 67: 613–618.PubMedGoogle Scholar
  20. 20.
    Robinson BF, Benjamin N, Phillips RJW (1984): Small increments in plasma calcium concentration reduce the responsiveness of forearm resistance vessels to verapamil in men with primary hypertension. J Hypertension 2 (suppl 3): 507–509.Google Scholar
  21. 21.
    Robinson BF, Dobbs RJ, Phillips RJW (1983): Effect of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension. Br J Clin Pharmacol 16: 327–332.PubMedGoogle Scholar
  22. 22.
    Bolli P, Erne P, Hulthén UL, Ritz R, Kiowski W, Ji BH, Bühler FR (1984): Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and β-adrenoceptor blockade. J Cardiovasc Pharmacol 6: S996–S1001.PubMedCrossRefGoogle Scholar
  23. 23.
    MacGregor GA, Markandu ND, Rotellar C, Smith SJ, Sagnella GA (1983): The acute response to nifedipine is related to pre-treatment blood pressure. Postgrad Med J 59 (suppl 2): 91–94.PubMedGoogle Scholar
  24. 24.
    Lederballe Pedersen O, Christensen NJ, Rämsch KD (1980): Comparison of acute effects of nifedipine in normotensive and hypertensive man. J Cardiovasc Pharmacol 2: 357–366.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht. 1987

Authors and Affiliations

  • Brian F. Robinson

There are no affiliations available

Personalised recommendations